Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Nevada Tech Journal.
Press releases published on June 23, 2025

TerraZero Announces PlayStar Casino Intraverse Activation
VANCOUVER, British Columbia, June 23, 2025 (GLOBE NEWSWIRE) -- BIGG Digital Assets Inc. (“BIGG” or the “Company”)(TSXV: BIGG; OTCQX: BBKCF; WKN: A2PS9W), a leading innovator in the digital assets space and owner of TerraZero, Netcoins and Blockchain …

SEALSQ, ColibriTD, and Xdigit Announce Plan to Develop a Breakthrough Quantum Computing Based Solution Set to Revolutionize Semiconductor Wafer Yields for Sub-7nm Nodes
Geneva, Switzerland, June 23, 2025 (GLOBE NEWSWIRE) -- By addressing IR Drop at sub-7nm nodes, the solution can significantly boost wafer yields, potentially saving manufacturers millions in production costs; improving yield from 50% to 80% on a single …

New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease
SAN FRANCISCO, June 23, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) announced the results from two large-scale real-world studies presented at the American Diabetes Association’s 85th Scientific Sessions (ADA 2025). The analyses …

Biomarkers Market worth US$104.15 billion in 2030 with 10.8% CAGR | MarketsandMarkets™.
Delray Beach, FL, June 23, 2025 (GLOBE NEWSWIRE) -- The global biomarkers market, valued at US$58.07 billion in 2024 stood at US$62.39 billion in 2025 and is projected to advance at a resilient CAGR of 10.8% from 2025 to 2030, culminating in a forecasted …

Eyenovia Announces Closing of $50 Million Private Placement, Successful Accumulation of More Than One Million HYPE Tokens, and Update on its Optejet Development Program
The significant HYPE token position, acquired at an average price of approximately $34 per token, makes Eyenovia the first Nasdaq listed company to run a validator on Hyperliquid FDA registration of the Optejet User Filled Device (UFD) on track for …

BOSS Money Ranked Highest by Customers Among Money Transfer Companies
Newark, NJ, June 23, 2025 (GLOBE NEWSWIRE) -- BOSS Money, the remittance and payments brand of IDT Corporation (NYSE: IDT), achieved the highest average app store rating of the eighteen digital money transfer companies in FXC Intelligence’s 2025 customer …

La Rosa Relies on Lofty to Support National Expansion Strategy
PHOENIX, June 23, 2025 (GLOBE NEWSWIRE) -- Award-winning real estate technology innovator, Lofty today announced customer La Rosa Holdings Corp. (NASDAQ: LRHC), a real estate and PropTech company, has partnered with the Lofty team to support the company’s …

Telos Corporation Reaches 350 TSA PreCheck Enrollment and Renewal Locations Nationwide
ASHBURN, Va., June 23, 2025 (GLOBE NEWSWIRE) -- Telos Corporation (NASDAQ: TLS), an authorized enrollment provider, continues to expand its nationwide TSA PreCheck® enrollment network with the opening of 41 new TSA PreCheck enrollment locations in May and …

BioStem Technologies Completes Enrollment in Clinical Trial Evaluating BioREtain® Amnion Chorion for Treatment of Diabetic Foot Ulcers
Head-to-head study comparing BioREtain®- processed Amnion Chorion (BR-AC) allograft to standard of care initiated in Q4 2024 to demonstrate healing superiority Topline results and full data analysis expected in Q4 2025 POMPANO BEACH, Fla., June 23, 2025 ( …

XRP DeFi Breakout: Martini Market Presale Soars Past 40% as Confidence Grows Amid Market Uncertainty
DUBAI, United Arab Emirates, June 23, 2025 (GLOBE NEWSWIRE) -- Despite global tensions unfolding, including U.S. airstrikes on Iranian nuclear facilities and escalating conflict in the Middle East, Martini Market’s $MRT presale is defying market anxiety. …

NKGen Biotech Announces International and U.S. Expansion of Phase 1/2a Troculeucel Alzheimer’s Trial with Activation of Clinical Sites in Canada and Florida
SANTA ANA, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer …

Candel Therapeutics Appoints Charles Schoch as Chief Financial Officer
NEEDHAM, Mass., June 23, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …

Firefly Neuroscience to be Added to the Russell Microcap® Index
– Comes less than a year after listing on Nasdaq – KENMORE, N.Y., June 23, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that …

Botpress Raises $25M Series B to Scale AI Agent Infrastructure
MONTREAL, June 23, 2025 (GLOBE NEWSWIRE) -- Botpress, a platform for building and deploying AI agents, today announced it has raised $25 million USD in Series B funding. The round was led by FRAMEWORK with participation from Inovia Capital, Deloitte …

Ashvattha Therapeutics Reports the Ability to Tune Nanomedicines to Image Neuroinflammation in Multiple Sclerosis Patients and Tumor Associated Macrophages in Cancer at SNMMI Annual Meeting
Novel nanomedicine radiotracer crosses blood brain barrier in patients with neuroinflammation Tumor macrophage radiotracer achieves 41.6% peak tumor uptake in preclinical studies REDWOOD CITY, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Ashvattha …

MBX Biosciences Appoints Andreas Moraitis, M.D., as Senior Vice President of Clinical Development
CARMEL, Ind., June 23, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic …

Chiesi Global Rare Diseases Awards Research Grants to Advance Innovation in Lysosomal Diseases
PARMA, Italy, June 23, 2025 (GLOBE NEWSWIRE) -- Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people living with rare diseases, today announced the recipients of its "Find For …

Optime Care Partners with Tilde Sciences as Exclusive Specialty Pharmacy Provider for Vecamyl
ST. LOUIS, June 23, 2025 (GLOBE NEWSWIRE) -- Optime Care, AscellaHealth’s Specialty Pharmacy, is pleased to announce an expanded partnership with Tilde Sciences LLC (“Tilde”), effective June 23, 2025. Under this arrangement, Optime Care will serve as the …

Guardforce AI Strengthens Decade-Long Client Relationships by Securing Long-term Contract with Government Savings Bank
NEW YORK, NY, June 23, 2025 (GLOBE NEWSWIRE) -- Guardforce AI Co., Limited (Nasdaq: GFAI, GFAIW) (“Guardforce AI” or the “Company”), a global integrated security solutions provider specializing in secured logistics, AI, and Robot-as-a-Service (RaaS), today …

Data Demonstrating Sotagliflozin Reduces the Risk of Clinically Important Hypoglycemic Events in Adults with Type 1 Diabetes When Added to Insulin Presented at the 85th Scientific Sessions of the American Diabetes Association (ADA)
Oral presentation highlighted the post-hoc analysis during the “Interventions to Prevent Hypoglycemia: Bench to Bedside” session Treatment with sotagliflozin resulted in no increased risk and a reduction in hypoglycemia events, particularly in patients …